Skip to main content
. 2022 Jun 19;117(11):2899–2906. doi: 10.1111/add.15967

FIGURE 2.

FIGURE 2

Prevalence of drugs detected among SCRA and non‐SCRA exposure cases. Note: SCRA exposure cases are those where at least one SCRA was detected, non‐SCRA exposure cases are those where no SCRAs, but at least one drug (previously controlled under the MDA before July 2015) was detected. SCRA, synthetic cannabinoid receptor agonist; THC, delta‐9‐tetrahydrocannabinol; MDA, Misuse of Drugs Act; MDMA, 3,4‐methyl​enedioxy​methamphetamine